AstraZeneca Confirms Exploring Potential Strategic Options With Acerta Pharma - AstraZeneca (NASDAQ:AZN)

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

Further to recent speculation, AstraZeneca (NYSE: AZN) confirms that it is exploring potential strategic options with Acerta Pharma BV. There can be no certainty that any transaction will ultimately be entered into, or as to the terms of any transaction.The Company will make a further announcement if and when appropriate.

27% profit every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Dow Jones

first reported a potential deal between the companies on Friday.AstraZeneca shares closed down $0.22 on Friday, at $33.25.